Pharmacology & ToxicologybioRxivPreprint
AI-Driven Virtual Screening and First-in-Class Conformational Biosensor Enable the Discovery of a GPR183 Inverse Agonist
Louise Andersson, Michele Roggia, Kittikorn Wangriatisak…·Paweł Kozielewicz
The paper discovers a GPR183 inverse agonist using AI-driven virtual screening and a conformational biosensor, showing inhibition of Gi activation and β-arrestin2 recruitment.
DOI 10.1101/2025.06.19.659764